Introduction Climate change from greenhouse gas (GHG) emissions represents one of the
greatest public health threats of our time. Inhalers (and particularly metred-dose inhalers …

Background Poorly controlled asthma is associated with increased morbidity and healthcare
resource utilisation (HCRU). Therefore, to quantify the environmental impact of asthma care …

Over the past few years, multiple health agencies from across the globe have recommended
schemes to reduce the carbon footprint of inhalers, encouraging a switch to environmentally …

Background Inhaled therapies are key components of asthma and chronic obstructive
pulmonary disease (COPD) treatments. Although the use of pressurised metered-dose …

Introduction Asthma exacerbations are a primary driver of costs and health impacts from
asthma. Despite research suggesting that asthma care has a disproportionate carbon …

Background While effective asthma control medications reduce the burden of asthma, a
significant subgroup of these treatments, namely metered-dose inhalers (MDIs), produce …

In the UK, the National Health Service (NHS) identified that inhalers contributed 3% of NHS
carbon emissions and aims to substitute high-carbon metered dose inhalers (MDIs) with low …

Aims Pressurised metered‐dose inhalers (MDIs) have a much higher carbon footprint than
dry powder inhalers (DPIs). We aimed to describe variations of inhaler options in local adult …

Background: Understanding the carbon footprint of respiratory care will identify strategies for
reduction. Uncontrolled asthma increases exacerbation risk and healthcare resource …

Objectives Dry powder inhalers (DPIs) and soft mist inhalers have a substantially lower
global warming potential than pressurised metered-dose inhalers (pMDIs). To help mitigate …